Top Upgrades today in the Buzz

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  12 Mar 2026
 

$COO The Cooper Companies drew renewed support after Needham lifted its price target and maintained a Buy rating, signaling confidence that improving demand trends are beginning to show through in the results. Analysts pointed to a solid start to the year and strengthening end-market dynamics as reasons the stock could work higher from oversold territory. With shares trading well below analyst targets and volume trending above average, the setup suggests investors may be quietly repositioning around the healthcare device name.

$CX CEMEX received a meaningful sentiment shift as Scotiabank upgraded the stock from Sector Perform to Sector Outperform. The call reflects growing optimism around infrastructure demand and improving construction cycles, which could help the cement giant benefit from stronger pricing and operational leverage. Even after recent volatility, analysts still see double-digit upside, indicating that institutional desks may be warming again to cyclical building materials exposure.

$ENB Enbridge continues to attract bullish commentary from the energy research community. Analysts reiterated an Outperform view while highlighting the massive project backlog, which provides long-term visibility into cash flow growth. Pipeline infrastructure names often trade as defensive yield plays, and with a multibillion-dollar development pipeline ahead, the market appears to be reassessing the durability of Enbridge earnings profile.

$ENVX Enovix remains one of the more speculative but closely watched battery technology stories on the board. Although analysts trimmed price targets, they maintained Buy ratings as the company continues to scale its next-generation battery platform. The spread between the current price and analyst targets remains extremely wide, suggesting that investors see significant potential if the commercialization roadmap stays on track.

$EVGO EVgo is another high-beta clean-energy name receiving continued analyst backing despite lower price targets. Firms reiterated Buy ratings, emphasizing the long-term growth opportunity tied to the expansion of EV charging infrastructure. With the stock trading at a fraction of prior levels, analysts appear to view the current valuation as a long-term entry point rather than a signal of weakening fundamentals.

$GAP The Gap regained attention after Goldman Sachs reiterated its Buy rating following investor meetings with management. Analysts described the tone from leadership as constructive, highlighting ongoing momentum across key brands and operational improvements. Retail turnaround stories often hinge on execution consistency, and the confidence suggests the apparel giant may still have room to re-rate if momentum holds.

$HAS Hasbro entered the research spotlight as Wells Fargo initiated coverage with an Equal-Weight rating. While not an outright bullish call, the move brings renewed institutional focus to the toy and entertainment company as it continues navigating shifts in consumer demand and entertainment partnerships. Analysts appear to be waiting for clearer catalysts before becoming more aggressive on the name.

$HOG Harley-Davidson also received new coverage, though with a more cautious tone as Wells Fargo initiated with an Underweight rating. Even with that conservative stance, analysts acknowledge potential upside in the shares, reflecting the tension between cyclical consumer demand and the brand strong legacy positioning in the motorcycle market.

$HWM Howmet Aerospace continues to show strength in the aerospace supply chain as analysts maintain bullish outlooks on the stock. Demand tied to aircraft manufacturing and defense programs has kept sentiment positive, with Wall Street broadly classifying the company as a Strong Buy. The structural tailwinds, including aircraft backlog growth, keep names like Howmet firmly on institutional watchlists.

$IRD Opus Genetics attracted attention after BTIG raised its price target and reiterated a Buy rating. The firm noted that the investment narrative is gaining traction following key developments in its pipeline. Small-cap biotech upgrades often come with elevated volatility, but the revised target signals increasing analyst confidence in the clinical progress.

$ISRG Intuitive Surgical received a notable upgrade from Citigroup, which moved its rating from Neutral to Buy. The call reflects continued confidence in the company’s leadership in robotic-assisted surgery, a field that continues to expand globally. With strong margins and recurring revenue from surgical systems and instruments, the upgrade suggests analysts see another leg of growth ahead for the med-tech leader.

$JEF Jefferies made a bold call on the retail side, upgrading the company to Buy and suggesting the stock could potentially double from current levels. The upgrade highlights improving fundamentals and an attractive valuation after recent weakness. Such aggressive upside commentary tends to catch traders’ attention, especially when paired with strong trading volume.

$KO Coca-Cola continues to earn quiet support from analysts who view the beverage giant as a long-term compounder despite recent consolidation in the stock. Dividend stability and global brand strength remain the core reasons analysts keep the name firmly in the Buy category, reinforcing its role as a defensive anchor within many portfolios.

$MAT Mattel entered the spotlight after Wells Fargo initiated coverage with an Overweight rating. Analysts see renewed potential following the efforts to strengthen brand franchises and expand media partnerships. With expectations for meaningful upside from current levels, the toy maker may benefit from both product innovation and entertainment tie-ins.

$OCGN Ocugen drew speculative interest after Oppenheimer initiated coverage with an Outperform rating. The firm pointed to substantial theoretical upside tied to the biotechnology pipeline. Early-stage biotech calls like this often generate strong trader interest, particularly when the projected upside dwarfs the current market price.

$ORCL One of the most influential upgrades of the session came as JPMorgan lifted Oracle from Neutral to Overweight. The call reflects increasing confidence in the cloud infrastructure and enterprise software ecosystem. With demand for AI-driven computing power accelerating, analysts believe Oracle positioning in cloud services could unlock significant upside from current levels.

$PLNT Planet Fitness also gained new attention as KeyBanc initiated coverage with an Overweight rating. Analysts see structural growth in the affordable fitness segment, where the membership model and expansion strategy continue to drive steady growth. The call suggests Wall Street sees the franchise model as resilient even in uncertain consumer environments.

$RKLB Rocket Lab remains one of the more intriguing names in the space economy theme. After a strategic reset, analysts upgraded the stock to Buy, highlighting improved execution and expanding opportunities in satellite launch services. As commercial space demand grows, the role as a smaller but agile launch provider keeps it firmly on traders’ radar.

View All Headlines